Haematologica, Vol 92, Issue 10, 1433-1434 doi:10.3324/haematol.11536
Copyright © 2007 by Ferrata Storti Foundation
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rowe, D.
Right arrow Articles by Jones, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rowe, D.
Right arrow Articles by Jones, G.

Acute Myeloid Leukemia

A case of acute myeloid leukemia with inv(16)(p13q22) reveals a novel MYH11 breakpoint and a new CBFß-MYH11 transcript variant

David Rowe*,, Lisa Strain*, Chris Lowe*, Gail Jones°

* Institute of Human Genetics, Newcastle upon Tyne, UK
° Dept. of Hematology, Royal Victoria Infirmary, Newcastle upon Tyne, UK

Correspondence: David Rowe, Institute of Human Genetics, Central Parkway, Newcastle upon Tyne, NE1 3BZ United Kingdom. Phone: international +44.191.2418793. Fax: international +44.191.2418713. E-mail: david.rowe{at}ncl.ac.uk

We present a case of acute myeloid leukemia (AML) with a cytogenetically typical inv(16)(p13q22), M4 morphology and eosinophilia. However, studies revealed a CBFß-MYH11 fusion transcript which did not correspond to any of the 10 known variants. Subsequent sequencing revealed a new in-frame transcript variant resulting from a novel MYH11 exon 32 breakpoint and a seven base insertion at the fusion point. The patient remains in complete remission following standard protocols. Prognostic implications cannot, therefore, be evaluated.

Key words: leukemia, inv(16), MYH11, variant.